[
  {
    "ts": null,
    "headline": "Trump Trade: Fannie, Freddie ordered to explore crypto as federal mortgage asset",
    "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump with this daily recap compiled by The Fly: CRYPTO AS FEDERAL MORTGAGE ASSET: FHFA Director William Pulte has ordered Fannie Mae (FNMA) and Freddie Mac (FMCC) to explore crypto as an asset for single-family mortgage applications without converting it to U.S. dollars, CNBC’s MacKenzie Sigalos reports. Only digital assets held on U.S.-regulated, ce",
    "url": "https://finnhub.io/api/news?id=ed129591b92ce9409e07ff08296b16d7e57b39fefbbe9824b167ecadcb433a88",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751038575,
      "headline": "Trump Trade: Fannie, Freddie ordered to explore crypto as federal mortgage asset",
      "id": 135591387,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump with this daily recap compiled by The Fly: CRYPTO AS FEDERAL MORTGAGE ASSET: FHFA Director William Pulte has ordered Fannie Mae (FNMA) and Freddie Mac (FMCC) to explore crypto as an asset for single-family mortgage applications without converting it to U.S. dollars, CNBC’s MacKenzie Sigalos reports. Only digital assets held on U.S.-regulated, ce",
      "url": "https://finnhub.io/api/news?id=ed129591b92ce9409e07ff08296b16d7e57b39fefbbe9824b167ecadcb433a88"
    }
  },
  {
    "ts": null,
    "headline": "Cigna Enables Coverage for RhinAer®",
    "summary": "MOUNTAIN VIEW, Calif., June 27, 2025--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide coverage for RhinAer® treatment of the posterior nasal nerve (CPT 31242), effective September 15, 2025. This change removes RhinAer from Cigna’s list of procedures deemed experimental, investigational, and unproven, marking a significant step forward in expanding access to a best-in-class treatment option for patients",
    "url": "https://finnhub.io/api/news?id=e547be5bb8b673cb7048c126623e15ce2259c0e5a4b8334ed15462b0f1bbe883",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751036400,
      "headline": "Cigna Enables Coverage for RhinAer®",
      "id": 135597496,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "MOUNTAIN VIEW, Calif., June 27, 2025--Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide coverage for RhinAer® treatment of the posterior nasal nerve (CPT 31242), effective September 15, 2025. This change removes RhinAer from Cigna’s list of procedures deemed experimental, investigational, and unproven, marking a significant step forward in expanding access to a best-in-class treatment option for patients",
      "url": "https://finnhub.io/api/news?id=e547be5bb8b673cb7048c126623e15ce2259c0e5a4b8334ed15462b0f1bbe883"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights Cigna, Humana, Centene and Molina Healthcare",
    "summary": "CNC, MOH, CI, and HUM are set to benefit from Medicare demand, steady premiums, and tech-driven growth in the HMO space.",
    "url": "https://finnhub.io/api/news?id=6f0dd9642eed2f6e9cfacc07117ea86fceda8fdec32b5a25b69b8a5d1668a6a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751012820,
      "headline": "Zacks Industry Outlook Highlights Cigna, Humana, Centene and Molina Healthcare",
      "id": 135590055,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "CNC, MOH, CI, and HUM are set to benefit from Medicare demand, steady premiums, and tech-driven growth in the HMO space.",
      "url": "https://finnhub.io/api/news?id=6f0dd9642eed2f6e9cfacc07117ea86fceda8fdec32b5a25b69b8a5d1668a6a1"
    }
  },
  {
    "ts": null,
    "headline": "Congress should reconsider breaking up pharmacy benefit managers, experts say",
    "summary": "Many popular proposals to reform the PBM industry are missing the forest for the trees, drug market experts said in Washington, D.C. Instead, Congress should go after the root issue: the oligopoly enjoyed by the Big Three PBMs.",
    "url": "https://finnhub.io/api/news?id=b7a114e106f0f1639224bf1d3cd28cb1cf97d359901856ebb87eba12b675af8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751007600,
      "headline": "Congress should reconsider breaking up pharmacy benefit managers, experts say",
      "id": 135592950,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "Many popular proposals to reform the PBM industry are missing the forest for the trees, drug market experts said in Washington, D.C. Instead, Congress should go after the root issue: the oligopoly enjoyed by the Big Three PBMs.",
      "url": "https://finnhub.io/api/news?id=b7a114e106f0f1639224bf1d3cd28cb1cf97d359901856ebb87eba12b675af8e"
    }
  }
]